A small trial in China suggests acupoint thread embedding may help women lose weight. Participants who received the treatment lost about 2kg more on average than those given a sham treatment after 12 weeks. At 24 weeks, the difference had grown to about 3kg.

The study was published in the Annals of Internal Medicine and randomly assigned 132 women to real or sham treatment. Experienced acupuncturists, specially trained for the study, gave six sessions over 12 weeks.

In acupoint thread embedding, fine needles are used to insert 1–2cm absorbable threads into selected points on the body. Practitioners look for a sensation known as de qi to check that the points are being stimulated. The threads, made of biodegradable polydioxanone, were inserted 2–4cm deep and dissolve over several weeks.

In standard acupuncture, needles are inserted into the same points and produce the same sensation, but are removed at the end of each session. Thread embedding may therefore have longer-lasting effects and could mean fewer, less frequent treatments, although the study did not test this.

For the sham treatment, the same acupuncturists used the same type of needles at the same points, but inserted them only 1cm. This did not trigger the de qi sensation—described as aching or tingling—and no threads were used. The women, staff measuring results and statisticians did not know which treatment participants received.

Researchers measured participants at the start of the study, at 12 weeks and at 24 weeks. They tracked weight, body mass index (BMI), waist and hip size, body fat, heart and metabolic health, and self-reported measures such as appetite.

Women who received the threads had larger reductions in BMI, waist and hip size, body fat and self-reported appetite, as well as the greater weight loss. The treatment made no difference to cholesterol or fasting blood sugar compared with the sham treatment, and did not affect anxiety, wellbeing or weight-related quality of life.

Side-effects such as bruising or pain at acupuncture points, and the number of women who left the study, were similar in both groups. Larger studies are needed to identify rare side-effects and determine whether results vary between groups, such as women who start at a higher weight.

Participants were Chinese women aged 18 to 45 who were generally healthy and had a BMI of at least 24 at the start. In the UK, a BMI of at least 25 is considered overweight; in China, a BMI of 24 counts as overweight because the effect of BMI on health varies by ethnicity. The study cannot establish whether the treatment works for men, women over 45 or under-18s.

The researchers did not establish how the threads led to weight loss. Women who received them reported a bigger drop in appetite, which suggests changes in eating habits might partly explain the result. But food intake and energy burned were not measured, so it is not known whether participants ate less or whether another factor was involved.

The weight loss lasted for 12 weeks after the 12-week course ended. The study does not show whether the weight will stay off over a longer period. The article notes that most people regain weight in the months and years after behaviour-change programmes, weight-loss drugs and other treatments, and that regular support from health professionals can soften this.

Larger studies should examine other groups and longer periods, test whether top-up treatments are needed, and compare costs and benefits with treatments recommended in official guidelines. The findings could help health services decide whether to offer acupoint thread embedding.